Angiogenesis: the VE-cadherin switch.
Because angiogenesis is a key step in a number of pathologic processes, including tumor growth and atherosclerosis, many research studies have investigated the regulatory signals active at various stages of vascular invasion. The differential activities of the endothelial junction protein vascular endothelial (VE)-cadherin reflect the versatile behavior of endothelial cells between vascular quiescence and angiogenesis. VE-cadherin function and signaling are deeply modified in proliferating cells, and this conversion is accompanied by phosphorylation of the protein on tyrosine residues and enhanced transcription of its gene. Recent advances in the complex interplay between protein tyrosine kinases and phosphatases regulating VE-cadherin phosphorylation and function are discussed in this review.
Wallez
Yann
Y
Laboratoire de Développement et Vieillissement de l'Endothélium, Université Joseph Fourier, Grenoble, France.
Vilgrain
Isabelle
I
Huber
Philippe
P
D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D050197:Atherosclerosis / Q000209:etiology / Q000473:pathology*; D015820:Cadherins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D002199:Capillary Permeability; D002453:Cell Cycle / Q000502:physiology; D042783:Endothelial Cells / Q000502:physiology; D004730:Endothelium, Vascular / Q000473:pathology / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000209:etiology*; D010766:Phosphorylation; D014443:Tyrosine / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism; D000099152:Cadherin 5
D015703:Antigens, CD; D015820:Cadherins; D014443:Tyrosine; D040301:Vascular Endothelial Growth Factor Receptor-2; D000099152:Cadherin 5